GLP-1 Drug Interactions: What Else You're Taking Matters

Medically reviewed by: Last updated: Reviewed for: Clinical accuracy, alignment with current obesity-medicine guidance and FDA labeling, and JumpstartMD treatment protocols.

How GLP-1s Change the Way Other Drugs Work

The most important mechanism behind nearly every GLP-1 interaction is delayed gastric emptying — the same effect that helps you feel full longer. By slowing how fast food and pills leave your stomach, GLP-1 medications can alter how quickly (and sometimes how completely) an oral drug is absorbed ¹, ³. This applies only to medications you swallow; injected, transdermal (patch), inhaled, and most implanted medications bypass the stomach and are unaffected.

The size of this effect varies by drug. For injectable semaglutide (Ozempic, Wegovy), FDA labeling notes that while the drug delays gastric emptying, formal studies "did not affect the absorption of orally administered medications to any clinically relevant degree" ³, ⁴. The effect is also largest after your first dose and diminishes with each subsequent dose as your stomach adapts ¹. So the concern is real in theory, but for most everyday medications it doesn't translate into a meaningful problem.

The drugs where it can matter are those with a narrow therapeutic index — where the gap between too little and too much is small, such as warfarin, certain thyroid and seizure medications, and some immunosuppressants. For these, the FDA advises increased clinical or laboratory monitoring (for example, checking INR more often on warfarin) when starting or changing a GLP-1 dose ³, ⁴, ⁵. For more on how these drugs behave in the body, see how GLP-1 medications work.

Medications That Need Extra Attention

Oral birth control (especially with tirzepatide)

This is the best-documented and most actionable GLP-1 interaction. Because tirzepatide delays gastric emptying, it can reduce the effectiveness of oral hormonal contraceptives. In FDA studies, a single 5 mg dose reduced peak blood levels of the contraceptive hormones ethinyl estradiol, norgestimate, and norelgestromin by 59%, 66%, and 55%, with overall exposure (AUC) down about 20% ¹, ².

Because of this, the labeling for both Mounjaro and Zepbound advises women on oral contraceptives to switch to a non-oral method (IUD, implant, injection, patch, or ring), or add a barrier method like condoms, for 4 weeks after starting and for 4 weeks after each dose increase ¹, ². Non-oral methods are not affected. Injectable semaglutide has not shown a clinically meaningful effect here, but the contraception conversation matters for anyone of reproductive age — GLP-1s aren't recommended in pregnancy, and weight loss itself can restore fertility. See GLP-1s, pregnancy, and fertility.

Levothyroxine and thyroid medication

Oral semaglutide (Rybelsus®) carries a specific note: when taken with levothyroxine, total thyroxine (T4) exposure rose by about 33% in a drug-interaction study ⁵. Rybelsus must be taken on an empty stomach with no more than 4 ounces of water, and all other oral medications — including thyroid hormone — should be taken at least 30 minutes later ⁵. If you take thyroid medication and a GLP-1, your clinician may check thyroid labs after you start or change doses. (Separately, GLP-1s carry a boxed warning about thyroid C-cell tumors in animal studies — a contraindication issue, not an interaction, covered in who qualifies.)

Warfarin and other narrow-margin drugs

If you take warfarin, your clinician may check your INR more closely when you start or change a GLP-1 dose, since shifts in absorption (and in diet, as you eat less) can move your levels ³, ⁴. The same principle applies to seizure medications, some heart-rhythm drugs, and transplant immunosuppressants — the fix is measurement, not avoidance.

Diabetes Medications: Insulin and Sulfonylureas

GLP-1 medications lower blood sugar in a glucose-dependent way, so on their own they rarely cause hypoglycemia (low blood sugar). But combined with insulin or a sulfonylurea (glipizide, glyburide, glimepiride), the risk of hypoglycemia — including severe hypoglycemia — goes up ¹, ³, ⁴. These older drugs push your body to release insulin regardless of your glucose level, and stacking that on a GLP-1's effects (plus eating less) can drop your blood sugar too far.

The FDA labeling explicitly advises considering a reduction in the dose of insulin or the insulin secretagogue when starting a GLP-1 ³, ⁴. This is a managed adjustment, not a reason to avoid the combination — many people take a GLP-1 and insulin successfully, with closer monitoring during the first weeks and each dose increase. More in do GLP-1s cause low blood sugar?.

Can I Take Semaglutide While Using NSAIDs?

Yes — you can generally take semaglutide with NSAIDs (ibuprofen, naproxen, aspirin, diclofenac), but caution is warranted. There is no direct pharmacological interaction between the two. The concern is that semaglutide and NSAIDs independently stress the same two systems — your gastrointestinal tract and your kidneys — in ways that can compound.

The gut. Semaglutide commonly causes nausea and slowed stomach emptying, while NSAIDs erode the stomach's protective lining — together raising the risk of stomach irritation, ulcers, and bleeding, especially with regular NSAID use.

The kidneys — the bigger concern. Your kidneys rely on prostaglandins to dilate the small arteries feeding them and keep blood flowing when you're low on fluid. NSAIDs block prostaglandin production, removing that protection ⁶. If semaglutide has left you dehydrated — from reduced fluid intake, nausea, or vomiting — adding an NSAID can reduce kidney blood flow enough to cause acute kidney injury ⁶. The risk is highest in the early weeks (when GI side effects peak), in older adults, in anyone with kidney disease, and especially in people also on blood pressure medications — NSAID plus an ACE inhibitor or ARB plus a diuretic is the combination nephrologists call the "triple whammy" ⁶.

Safer choices: For occasional aches, acetaminophen (Tylenol®) is generally preferred because it lacks the same kidney and stomach risks. For chronic pain, topical NSAIDs (far lower blood levels) or non-drug approaches like physical therapy are worth discussing. If you do need an oral NSAID, use the lowest effective dose for the shortest time, stay well hydrated, and tell your clinician — including about over-the-counter products people often forget to mention.

Is It Safe to Take Tirzepatide With ACE Inhibitors?

Yes — tirzepatide and ACE inhibitors can be taken together safely. There is no known direct drug interaction between tirzepatide (Mounjaro, Zepbound) and ACE inhibitors such as lisinopril, enalapril, or ramipril (or the related ARBs like losartan and valsartan). The combination is often complementary, since both lower blood pressure. But safe use depends on active monitoring for two reasons.

1. Additive blood-pressure lowering. Tirzepatide lowers blood pressure on its own — in the SURMOUNT-1 trial it reduced systolic blood pressure by roughly 7–8 mmHg versus placebo, an effect driven mostly (about two-thirds) by weight loss ⁷. Layered on an ACE inhibitor, this adds up. As you lose weight, the ACE inhibitor dose that was right at the start may become too strong, causing dizziness, lightheadedness, or fainting — especially on standing. This is usually a good problem (your blood pressure medication can often be reduced), but it has to be managed by re-checking your blood pressure during dose escalation, not by guessing.

2. Kidney function. Like semaglutide, tirzepatide can cause nausea and vomiting that lead to dehydration. ACE inhibitors change how the kidney regulates its own blood flow, so dehydration on top of one raises the risk of acute kidney injury — the same vulnerability behind the NSAID combination above.

The takeaway: baseline kidney testing, regular blood pressure checks during dose increases, and proactive adjustment as weight comes off. Never self-adjust your blood pressure medication — but do expect your clinician may lower it over time. See semaglutide vs tirzepatide.

Dehydration: The Hidden Multiplier

If one thread connects almost every meaningful GLP-1 interaction, it's dehydration. Reduced appetite and thirst, plus occasional nausea or vomiting, can quietly lower your fluid volume — the state in which NSAIDs, ACE inhibitors, ARBs, diuretics ("water pills"), and SGLT2 inhibitors all become more likely to stress your kidneys. Dehydration is the multiplier that turns a benign combination into a risky one. Drink fluids deliberately even when you don't feel thirsty, don't push through repeated vomiting without telling your clinician, and ask whether any "as-needed" medications (especially NSAIDs and diuretics) should be paused on days you can't keep fluids down.

Is This Normal? When to Call Your Clinician

Some adjustment is expected — feeling a little lightheaded as your blood pressure improves, or needing a tweak to your diabetes regimen, is normal. Call your clinician (don't wait for your next visit) if:

• You feel dizzy, lightheaded, or faint, particularly when standing — your blood pressure medication may need reducing.
• You have symptoms of low blood sugar (shakiness, sweating, confusion, palpitations) and take insulin or a sulfonylurea.
• You can't keep fluids down for more than a day, or have ongoing vomiting or diarrhea.
• You take warfarin, thyroid, seizure, or any narrow-margin medication and are starting or increasing your GLP-1 dose.
• You take a blood pressure pill, diuretic, or NSAID and develop reduced urination, swelling, or unusual fatigue.

Red Flags — Seek Care Now

Seek urgent or emergency care if you experience:

• Fainting, or near-fainting with a very low blood pressure reading.
• Severe hypoglycemia — confusion, seizure, or loss of consciousness (and use glucagon if prescribed).
• Black, tarry, or bloody stools, or vomiting blood — possible GI bleed, more likely when NSAIDs and a GLP-1 are combined.
• Markedly reduced urination, severe swelling, or rapidly worsening fatigue and confusion — possible acute kidney injury, especially with the NSAID + blood-pressure-medication + dehydration combination.
• Severe, persistent abdominal pain (especially radiating to the back) — see serious side effects and red flags to distinguish ordinary nausea from pancreatitis.

What You Can Do About It

Before you start (with your clinician):

• Bring a complete list of everything you take — prescriptions, OTC drugs (especially NSAIDs and antacids), vitamins, and supplements.
• Flag insulin, sulfonylureas, blood pressure medications, diuretics, warfarin, thyroid medication, and oral contraceptives specifically, and get baseline labs including kidney function.

While you're on treatment:

• Hydrate deliberately, and pause as-needed NSAIDs or diuretics on days you can't keep fluids down (confirm with your clinician).
• Use acetaminophen rather than NSAIDs for occasional pain when possible.
• If you use oral birth control with tirzepatide, follow the backup-contraception window.
• Take Rybelsus on an empty stomach and space other oral pills at least 30 minutes later.
• Expect dose re-checks on blood pressure and diabetes medications as you lose weight — and never self-adjust them.
• Report dizziness, low-blood-sugar episodes, or persistent vomiting promptly.

Dose and medication decisions belong with your clinician, who re-titrates your other medications as your body changes — the core value of medically supervised GLP-1 care.

Get Started with JumpstartMD

If you take other medications and wonder whether a GLP-1 is safe to add, that question deserves a real clinical answer — not a guess. Drug-interaction screening is built into how JumpstartMD prescribes.

Founded in 2007 by Stanford-trained physicians, JumpstartMD builds every plan around labs, hormones, and body composition, with outcomes published in the peer-reviewed Journal of Obesity. You're seen face-to-face by a licensed clinician — in person at one of 14 California locations or online across California — not handed a prescription by an algorithm. A 69-biomarker lab screening establishes your baseline (including kidney and metabolic markers), and InBody® body-composition scanning tracks lean mass so you lose fat, not muscle — important because up to 40% of weight lost on GLP-1s can be muscle without supervision.

JumpstartMD offers the full range of FDA-approved options — Ozempic®, Wegovy®, Zepbound®, Mounjaro®, and Rybelsus® — plus non-GLP-1 and no-medication plans, with flexible dosing, microdosing, and maintenance support. Before any prescription, your clinician performs contraindication screening and a full drug-interaction review, then manages titration, monitors for interactions as you lose weight, and provides restart and step-down protocols to protect your results. Pricing is personalized — you pay for the dose prescribed, not a flat monthly fee — and health coaching and nutrition guidance are included in membership.

Book a free, no-obligation consultation by phone or online form to review your medications and find out whether a GLP-1 fits safely into your plan.

Ready to talk?

Book FREE Consultation

Share your details and a JumpstartMD team member will reach out shortly. Or call 408.478.3496 for your free, no-obligation consultation.

Related Articles

• Do GLP-1s cause low blood sugar? — the detail behind the insulin and sulfonylurea interaction.
• Serious side effects and red flags — recognizing the emergencies (GI bleed, kidney injury, pancreatitis) above.
• Who qualifies for GLP-1 treatment? — the contraindication screening that precedes any prescription.
• What medically supervised GLP-1 care includes — why ongoing monitoring is the safeguard.
• GLP-1 side effects overview — the nausea, vomiting, and dehydration that drive most interaction risk.
• GLP-1s, pregnancy, and fertility — the full contraception and conception-timing guidance.